Duality Advisers LP Acquires New Holdings in agilon health, inc. (NYSE:AGL)

Duality Advisers LP acquired a new stake in agilon health, inc. (NYSE:AGLFree Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 15,267 shares of the company’s stock, valued at approximately $192,000.

Other large investors have also recently added to or reduced their stakes in the company. Wellington Management Group LLP grew its stake in agilon health by 8.3% in the 3rd quarter. Wellington Management Group LLP now owns 41,318,777 shares of the company’s stock valued at $733,821,000 after acquiring an additional 3,162,094 shares during the last quarter. California Public Employees Retirement System boosted its stake in shares of agilon health by 27.7% during the 3rd quarter. California Public Employees Retirement System now owns 413,987 shares of the company’s stock worth $7,352,000 after purchasing an additional 89,728 shares during the last quarter. Morgan Stanley boosted its stake in shares of agilon health by 8.9% during the 3rd quarter. Morgan Stanley now owns 44,819,378 shares of the company’s stock worth $795,992,000 after purchasing an additional 3,674,311 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of agilon health by 4.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,796,884 shares of the company’s stock worth $31,913,000 after purchasing an additional 70,443 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of agilon health by 222.5% during the 3rd quarter. Tower Research Capital LLC TRC now owns 23,660 shares of the company’s stock worth $420,000 after purchasing an additional 16,324 shares during the last quarter.

agilon health Stock Down 2.6 %

Shares of NYSE:AGL opened at $5.00 on Friday. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.05. agilon health, inc. has a 52-week low of $4.41 and a 52-week high of $26.75. The company has a 50 day moving average of $5.55 and a two-hundred day moving average of $9.51. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of -7.68 and a beta of 0.49.

agilon health (NYSE:AGLGet Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. The firm had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same period last year, the business earned ($0.14) EPS. The firm’s revenue was up 71.8% compared to the same quarter last year. As a group, analysts forecast that agilon health, inc. will post -0.35 earnings per share for the current fiscal year.

Analyst Ratings Changes

AGL has been the topic of several analyst reports. Stifel Nicolaus decreased their price target on shares of agilon health from $10.00 to $9.00 and set a “hold” rating on the stock in a research note on Thursday, February 22nd. Barclays began coverage on shares of agilon health in a research note on Wednesday, March 6th. They set an “underweight” rating and a $5.00 price target on the stock. Wolfe Research lowered shares of agilon health from an “outperform” rating to a “peer perform” rating in a report on Monday, January 8th. SVB Leerink lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, January 8th. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $6.50 price objective (down from $25.00) on shares of agilon health in a report on Monday, February 26th. One research analyst has rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, agilon health has a consensus rating of “Hold” and an average target price of $9.46.

Read Our Latest Analysis on agilon health

agilon health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Recommended Stories

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.